BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4618288)

  • 21. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
    Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
    J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pimozide in the maintenance treatment of apathetic and emotionally withdrawn schizophrenics.
    Cheadle AJ; Freeman HL
    Curr Med Res Opin; 1979; 6(1):35-43. PubMed ID: 378556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. A clinical and experimental-psychological study.
    Cesarec Z; Eberhard G; Nordgren L
    Acta Psychiatr Scand Suppl; 1974; 249():65-77. PubMed ID: 4608707
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
    Abuzzahab FS; Zimmermann RL
    Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract]   [Full Text] [Related]  

  • 27. A multicenter multidimensional study of some new longacting neuroleptic drugs.
    Acta Psychiatr Scand Suppl; 1974; 249():1-134. PubMed ID: 4608507
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol.
    Silverstone T; Cookson J; Ball R; Chin CN; Jacobs D; Lader S; Gould S
    J Psychiatr Res; 1984; 18(3):255-68. PubMed ID: 6387105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pimozide: an effective, once daily oral therapy for schizophrenia.
    Van Wyk AJ; Grové JJ
    S Afr Med J; 1972 Apr; 46(17):515-7. PubMed ID: 4570652
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 Feb; 8(1):59-70. PubMed ID: 345313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pimozide and chlorpromazine in acute schizophrenia.
    Pecknold JC; McClure DJ; Allan T; Wrzesinski L
    Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial of pimozide.
    Anumonye A; Onibuwe-Johnson T; Marinho AA
    West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):17-24. PubMed ID: 799401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results obtained with Orap in the therapy of neuropsychiatric outpatients.
    Perényi G; Várkonyi B+VARKONYI B
    Ther Hung; 1974; 22(2):65-8. PubMed ID: 4608508
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and statistical evaluation of neuroleptic pimozide].
    Glatzel J
    Int Pharmacopsychiatry; 1971; 6(1):60-6. PubMed ID: 5163169
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
    Nurowska K; Welbel L
    Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
    [No Abstract]   [Full Text] [Related]  

  • 37. Pimozide as an adjuvant to maintenance therapy in chronic schizophrenia.
    Nakra BR; Wickramasinghe NA
    Pharmatherapeutica; 1980; 2(5):337-40. PubMed ID: 6107933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
    Donlon PT; Swaback DO; Osborne ML
    Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of pimozide in clinical psychiatry: a review.
    Opler LA; Feinberg SS
    J Clin Psychiatry; 1991 May; 52(5):221-33. PubMed ID: 2033030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
    Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.